PubRank

A Penna

Author PubWeight™ 70.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Practice guidelines developed by specialty societies: the need for a critical appraisal. Lancet 2000 8.10
2 Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells. Nature 1994 4.42
3 Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women. J Clin Oncol 1998 3.65
4 Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol 1990 3.31
5 Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 1996 3.17
6 Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest 1998 2.97
7 HLA class I-restricted human cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc Natl Acad Sci U S A 1991 2.83
8 Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology 1997 2.61
9 Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope. J Exp Med 1994 2.18
10 Identification of immunodominant T cell epitopes of the hepatitis B virus nucleocapsid antigen. J Clin Invest 1991 2.08
11 T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections. Hepatology 1994 2.00
12 Lamivudine treatment can overcome cytotoxic T-cell hyporesponsiveness in chronic hepatitis B: new perspectives for immune therapy. Hepatology 2001 1.99
13 Intrahepatic, nucleocapsid antigen-specific T cells in chronic active hepatitis B. J Immunol 1987 1.85
14 Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J Virol 1993 1.74
15 Short stay facilities: the future of efficient paediatric emergency services. Arch Dis Child 1996 1.64
16 Functional characterization of cloned intrahepatic, hepatitis B virus nucleoprotein-specific helper T cell lines. J Immunol 1987 1.25
17 Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B. Clin Exp Immunol 1986 1.14
18 Cellular immune response to hepatitis B virus antigens. An overview. J Hepatol 1988 1.05
19 Molecular features of the hepatitis B virus nucleocapsid T-cell epitope 18-27: interaction with HLA and T-cell receptor. Hepatology 1997 1.04
20 The preS1 antigen of hepatitis B virus is highly immunogenic at the T cell level in man. J Clin Invest 1989 1.02
21 Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens. Hepatology 2001 0.99
22 Parasitic diatoms inside antarctic sponges. Biol Bull 2000 0.97
23 Immunopathogenesis of hepatitis C virus infection. J Hepatol 1999 0.97
24 Influence of obesity on propofol pharmacokinetics: derivation of a pharmacokinetic model. Br J Anaesth 2010 0.96
25 Fine specificity of the human T-cell response to the hepatitis B virus preS1 antigen. Gastroenterology 1992 0.95
26 Gonadotropin-releasing hormone action in the pituitary: a three step mechanism. Endocr Rev 1981 0.93
27 Performance evaluation of paediatric propofol pharmacokinetic models in healthy young children. Br J Anaesth 2011 0.93
28 Antiviral cell-mediated immune responses during hepatitis B and hepatitis C virus infections. Recent Results Cancer Res 1998 0.92
29 Autopresentation of hepatitis B virus envelope antigens by T cells. J Virol 1992 0.86
30 Detection and quantification of Prymnesium parvum (Haptophyceae) by real-time PCR. Lett Appl Microbiol 2007 0.84
31 Inappropriate Halsted mastectomy and patient volume in Italian hospitals. Am J Public Health 1993 0.83
32 Effectiveness of different therapeutic strategies in preventing diverticulitis recurrence. Eur Rev Med Pharmacol Sci 2013 0.83
33 Clonal analysis of intrahepatic T lymphocytes in chronic active hepatitis. Isolation of a T-cell line specific for hepatitis B core antigen from a patient with serological evidence of exposure to HBV. J Hepatol 1986 0.81
34 Physicians' view of practice guidelines. A survey of Italian physicians. Soc Sci Med 1996 0.81
35 The influence of patient characteristics on the appropriateness of surgical treatment for breast cancer patients. Progetto Oncologia Femminile. Ann Oncol 1993 0.81
36 New insights into the biological and clinical significance of fecal calprotectin in inflammatory bowel disease. Immunopharmacol Immunotoxicol 2006 0.80
37 Cell mediated immune response to hepatitis B virus nucleocapsid antigen. Arch Virol Suppl 1993 0.80
38 Thymidine phosphorylase profiles in nonmalignant and malignant pancreatic tissue. Potential therapeutic role of capecitabine on tumoral and endothelial cells and tumor-infiltrating macrophages. Immunopharmacol Immunotoxicol 2005 0.80
39 Functional modulation of hepatitis B core antigen-specific T lymphocytes by an autoreactive T cell clone. J Immunol 1988 0.78
40 Variation in use of breast surgery and characteristics of hospitals' surgical staff. Int J Qual Health Care 1994 0.78
41 Capture probe conjugated to paramagnetic nanoparticles for purification of Alexandrium species (Dinophyceae) DNA from environmental samples. J Appl Microbiol 2006 0.78
42 Safety and effectiveness of infliximab for inflammatory bowel diseases in clinical practice. Eur Rev Med Pharmacol Sci 2010 0.78
43 Letter: are infliximab and adalimumab similar for Crohn's disease in clinical practice? Aliment Pharmacol Ther 2013 0.77
44 PreS antigen expression and anti-preS response in hepatitis B virus infections: relationship to serum HBV-DNA, intrahepatic HBcAg, liver damage and specific T-cell response. Arch Virol Suppl 1992 0.76
45 Study on the oligosaccharides composition of the water-soluble fraction of marine mucilage by electrospray tandem mass spectrometry. Water Res 2007 0.76
46 [A case of myocardial infarct caused by coronaritis]. Minerva Med 1982 0.75
47 [Promoting the improvement of clinical practice: guidelines]. Epidemiol Prev 1994 0.75
48 Clinical features of hepatitis delta virus infection in a northern Italian area. Infection 1988 0.75
49 [Tetrabiguanide: hematic and urinary concentrations in humans]. Boll Soc Ital Biol Sper 1967 0.75
50 [Correlations between trophism of the external genitalia and hormone levels during menopausal age]. Ann Ostet Ginecol Med Perinat 1991 0.75
51 [The immunopathogenesis of hepatitis B]. Ann Ital Med Int 1993 0.75
52 [Diuretics in cardiovascular pathology. Their clinical use in the light of recent pathogenetic studies]. Minerva Med 1984 0.75
53 [The effect of ursodeoxycholic acid in patients with liver cirrhosis and chronic hypertransaminasemia]. Minerva Gastroenterol Dietol 1994 0.75
54 [Radiological findings in a group of subjects treated with mitral commissurotomy]. Boll Soc Ital Cardiol 1966 0.75
55 Immune pathogenesis of hepatitis B. Arch Virol Suppl 1992 0.75
56 Crohn's appendicitis. Endoscopy 2010 0.75
57 [Uses, role and limitations of computerized tomography (CT) in mediastinal and cardiac diagnostics and the prospects of use of new related methods]. Clin Ter 1984 0.75
58 [Climacteric symptomatology: relation with hormone levels and trophic features of the external genitalia]. Ann Ostet Ginecol Med Perinat 1992 0.75
59 [The adjuvant treatment of operable breast carcinoma. The current status and outlook]. Recenti Prog Med 1993 0.75
60 Therapeutic organizer (TH.OR.): a new tool in critical patient management. Cardiovasc Drugs Ther 1999 0.75
61 [Gastric acidometry schistosomal in portal hypertension]. Rev Bras Malariol Doencas Trop 1968 0.75
62 [Electrocardiographic findings in a group of treated with mitral commissurotomy]. Boll Soc Ital Cardiol 1966 0.75
63 [Effects of Tettuccio water from the Montecatini spa on chronic constipation: clinical evaluation and study of intestinal motor activity]. Clin Ter 1984 0.75